Inventor · disambiguated record
Eric D. Turtle
Also filed as: TURTLE ERIC · TURTLE ERIC D · TURTLE ERIC DOUGLAS
28 granted patents·9 pending applications·535 citations·filing 2004–2024
97Inventor score
Top patents by PatentIndex Score
37 records- 0198US7323475B2Nitrogen-containing heteroaryl compounds and methods of use thereofFIBROGEN INC·Filed 2004·Granted Jan 29, 2008·97 cites·46 claims
- 0297US7629357B2Nitrogen-containing heteroaryl compounds and methods of user thereofFIBROGEN INC·Filed 2006·Granted Dec 8, 2009·38 cites·52 claims
- 0396US8017625B2Nitrogen-containing heteroaryl compounds and methods of use thereofFIBROGEN INC·Filed 2008·Granted Sep 13, 2011·42 cites·47 claims
- 0496US7863292B2Nitrogen-containing heteroaryl compounds and methods of use thereofFIBROGEN INC·Filed 2007·Granted Jan 4, 2011·28 cites·38 claims
- 0595US11124504B2Kappa opioid receptor antagonists and products and methods related theretoSCRIPPS RESEARCH INST·Filed 2020·Granted Sep 21, 2021·4 cites·81 claims
- 0695US8765956B2Nitrogen-containing heteroaryl compounds and methods of use thereofFIBROGEN INC·Filed 2013·Granted Jul 1, 2014·19 cites·19 claims
- 0795US8278325B2Nitrogen-containing heteroaryl compounds and methods of use thereofAREND MICHAEL P·Filed 2011·Granted Oct 2, 2012·22 cites·24 claims
- 0895US7928120B2Cyanoisoquinoline compounds and methods of use thereofFIBROGEN INC·Filed 2007·Granted Apr 19, 2011·40 cites·36 claims
- 0995US7696223B2Pyrrolo- and Thiazolo-pyridine compounds, and methods of use thereofFIBROGEN INC·Filed 2007·Granted Apr 13, 2010·54 cites·32 claims
- 1094US8324405B2Chromene derivatives and use thereof as HIF hydroxylase activity inhibitorsHO WEN-BIN·Filed 2009·Granted Dec 4, 2012·36 cites·18 claims
- 1193US8916585B2Nitrogen-containing heteroaryl compounds and methods of use thereofAREND MICHAEL P·Filed 2012·Granted Dec 23, 2014·16 cites·27 claims
- 1293US8759373B2Cyanoisoquinoline compounds and methods of use thereofAREND MICHAEL P·Filed 2012·Granted Jun 24, 2014·21 cites·33 claims
- 1393US8269008B2Oxazolopyridine and isoxazolopyridine derivatives for use in the treatment of HIF-mediated conditionsAREND MICHAEL P·Filed 2008·Granted Sep 18, 2012·37 cites·32 claims
- 1492US10676469B2Kappa opioid receptor antagonists and products and methods related theretoSCRIPPS RESEARCH INST·Filed 2018·Granted Jun 9, 2020·12 cites·59 claims
- 1590US9339527B2Nitrogen-containing heteroaryl compounds and methods of use thereofFIBROGEN INC·Filed 2014·Granted May 17, 2016·7 cites·20 claims
- 1688US11897873B2Kappa opioid receptor antagonists and products and methods related theretoSCRIPPS RESEARCH INST·Filed 2021·Granted Feb 13, 2024·1 cites·6 claims
- 1788US9174976B2Cyanoisoquinoline compounds and methods of use thereofFIBROGEN INC·Filed 2014·Granted Nov 3, 2015·9 cites·41 claims
- 1887US10092558B2Nitrogen-containing heteroaryl compounds and methods of use thereofFIBROGEN INC·Filed 2016·Granted Oct 9, 2018·3 cites·20 claims
- 1987US8927591B2Thiochromene derivatives as HIF hydroxylase inhibitorsHO WEN-BIN·Filed 2009·Granted Jan 6, 2015·12 cites·37 claims
- 2087US8703795B2Thienopyridine compounds, and methods of use thereofTURTLE ERIC D·Filed 2006·Granted Apr 22, 2014·17 cites·14 claims
- 2185US9000006B2Thienopyridine compounds, and methods of use thereofFIBROGEN INC·Filed 2014·Granted Apr 7, 2015·7 cites·14 claims
- 2284US9149476B2Thiochromene derivatives as HIF hydroxylase inhibitorsFIBROGEN INC·Filed 2014·Granted Oct 6, 2015·7 cites·37 claims
- 2379US8729112B2Antimicrobial haloalkyl heterocycle compoundsNOVABAY PHARMACEUTICALS INC·Filed 2012·Granted May 20, 2014·2 cites·12 claims
- 2475US11229637B2Nitrogen-containing heteroaryl compounds and methods of use thereofFIBROGEN INC·Filed 2020·Granted Jan 25, 2022·0 cites·12 claims
- 2571US12258332B2ASGPR cell surface receptor binding compounds and conjugatesLYCIA THERAPEUTICS INC·Filed 2023·Granted Mar 25, 2025·0 cites·18 claims
- 2671US10646482B2Nitrogen-containing heteroaryl compounds and methods of use thereofFIBROGEN INC·Filed 2018·Granted May 12, 2020·0 cites·20 claims
- 2771US2025101007A1Asgpr cell surface receptor binding compounds and conjugatesLYCIA THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 2864US8851091B2Contact lens cleaning system with monitorFRANCAVILLA CHARLES·Filed 2012·Granted Oct 7, 2014·4 cites·31 claims
- 2964US2007155784A1Novel nitrogen-containing heteroaryl compounds and methods of use thereofFIBROGEN INC·Filed 2006·Application pending·0 cites
- 3063US2024343719A1Kappa opioid receptor antagonists and products and methods related theretoSCRIPPS RESEARCH INST·Filed 2023·Application pending·0 cites
- 3156US2011212959A1Cyanoisoquinoline Compounds and Methods of Use ThereofFIBROGEN INC·Filed 2011·Application pending·0 cites
- 3255US2024335544A1M6pr cell surface receptor binding compounds and conjugatesLYCIA THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 3354US2016009653A1Cyanoisoquinoline compounds and methods of use thereofFIBROGEN INC·Filed 2015·Application pending·0 cites
- 3453US2024165250A1Bifunctional Folate Receptor Binding CompoundsLYCIA THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 3553US2025127913A1Bifunctional folate receptor binding compoundsLYCIA THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 3648US2023158155A1Cell Surface Receptor Binding Compounds and ConjugatesLYCIA THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 3735US9248117B2Substituted N,N-dihaloamines as antimicrobialsJAIN RAKESH K·Filed 2011·Granted Feb 2, 2016·0 cites·7 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →